Group 1 - The Chinese traditional medicine index (930641) has shown a slight increase of 0.20% as of July 25, 2025, with notable gains from companies such as Zhenbao Island (603567) up 5.92% and Fangsheng Pharmaceutical (603998) up 1.67% [1] - The Chinese traditional medicine ETF (159647) has increased by 0.19%, with a recent price of 1.03 yuan and a one-month growth of 5.56% [1] - The National Medical Products Administration has approved the first secondary protection variety of traditional Chinese medicine, the Xia Liqi Capsule from Shijiazhuang Yiling Pharmaceutical Co., with a protection period of seven years [1] Group 2 - Chinese innovative drug companies are transitioning from quantitative to qualitative changes, with expectations of significant business development (BD) transactions in the coming years, leading to potential mergers and acquisitions [2] - The next 5 to 10 years are anticipated to be a period of explosive growth for Chinese innovative drugs, with domestic companies expected to emerge as globally competitive multinational corporations (MNCs) [2] - The traditional Chinese medicine ETF closely tracks the traditional Chinese medicine index, which reflects the overall performance of listed companies involved in the production and sales of traditional Chinese medicine [2] Group 3 - As of June 30, 2025, the top ten weighted stocks in the traditional Chinese medicine index account for 55.96% of the index, including companies like Pian Zai Huang (600436) and Yunnan Baiyao (000538) [3]

Core Viewpoint - The conference highlighted the innovative application of the theory of "Luo Disease" in the diagnosis and treatment of prostate diseases, particularly focusing on the clinical research progress of the innovative Chinese medicine Xia Li Qi capsules, providing new solutions for the health of middle-aged and elderly men [1][3]. Group 1: Prostate Disease Insights - Prostate hyperplasia is the most common benign disease causing lower urinary tract symptoms in elderly men, with an incidence rate exceeding 50% in men over 60 years old and reaching 83% by age 80 [3]. - Traditional Chinese medicine categorizes prostate hyperplasia as "Luo Bi," primarily caused by "kidney deficiency and bladder dysfunction" [3]. Group 2: Xia Li Qi Capsules - Xia Li Qi capsules are developed based on the theory of Luo Disease, featuring a formulation that combines various herbs to create a treatment system that addresses both symptoms and root causes [4]. - Clinical studies have shown that Xia Li Qi capsules significantly reduce the International Prostate Symptom Score (IPSS), improve symptoms like urinary urgency and frequency, and effectively inhibit prostate enlargement [4]. Group 3: Clinical Guidelines and Future Directions - Xia Li Qi capsules have been included in multiple authoritative guidelines and consensus documents related to the management of benign prostate hyperplasia, establishing them as a preferred option for integrated treatment [5]. - The current treatment landscape for prostate hyperplasia faces challenges with symptom management, necessitating the exploration of traditional Chinese medicine's holistic approach for better disease management [5].

马建国教授指出，夏荔芪胶囊是医保乙类品种，基于确切的研究证据，获《泌尿生殖疾病中西医结合诊疗共识》《老年良性前列腺增生慢病管理指南》《良 性前列腺增生症中西医结合多学科诊疗指南》《良性前列腺增生诊疗及健康管理指南》《中西医结合诊疗前列腺炎专家共识》等指南、共识推荐，并入选西 学中教材《中医泌尿男科学》，为前列腺疾病患者提供新的治疗选择。（林梦茵） 马建国教授在报告中指出，目前，前列腺疾病发病率高且严重影响男性健康。常见的如良性前列腺增生，该病一般发生在40岁以后，发生率随年龄的增长而 逐年增加，51～60岁男性人群中约20％，61～70岁的发生率达50％，81～90岁时高达83％。下尿路症状则是前列腺增生患者的常见症候群，在45～80岁的男 性中，90%患有下尿路症状。下尿路症状是一系列与排尿相关的症状，包括尿频、尿急、尿失禁、夜尿增多等储尿期症状，排尿踌躇、排尿困难、排尿间断 等排尿期症状，以及排尿不尽感、尿后滴沥等排尿后症状，这些症状往往长期存在，并进行性加重，给患者造成极大困扰。 马建国教授认为，对于无前列腺手术指征的患者，下尿路症状的主要治疗方案为药物治疗，但是目前临床常规西药的安全性及疗效存在不足， ...

Core Viewpoint - The article highlights the health risks associated with excessive drinking and unhealthy eating during the "May Day" holiday, particularly the increased risk of prostate issues such as prostatitis and benign prostatic hyperplasia. Group 1: Health Risks - Alcohol consumption, especially beer and spirits, can lead to the expansion of prostate blood vessels, causing local congestion and edema, which may result in urinary difficulties for chronic prostatitis patients [3] - Heavy consumption of spicy and high-fat foods during gatherings can exacerbate prostate inflammation and may lead to constipation, further damaging prostate health [3] - Prolonged sitting during holiday activities can compress the prostate, impairing blood circulation, while lack of sleep can weaken the immune system, increasing the risk of infections [3] Group 2: Symptoms to Watch For - Early symptoms of prostate issues may include frequent urination, weak urine stream, and pelvic pain, which should not be ignored [4] - Serious symptoms may involve fatigue, insomnia, anxiety, and blood in urine or semen, indicating potential prostatitis or more severe conditions [4] Group 3: Preventive Measures - It is recommended that men limit alcohol intake to no more than 25 grams per day and avoid spicy and high-fat foods, opting instead for a diet rich in vegetables, fruits, and whole grains [5][6] - Regular physical activity is advised, with breaks every hour to promote pelvic blood circulation and reduce prostate pressure [6] - Maintaining a regular sleep schedule and seeking medical attention for any concerning symptoms is crucial, especially as the incidence of prostate diseases increases with age [7]